FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,276 letters match. Newest first.

  1. Specialty Process Labs LLC

    FDA warned Specialty Process Labs about manufacturing quality failures for thyroid USP active ingredient, including unvalidated processes and data control gaps.

    High risk
  2. Inhousepharmacy.vu

    Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.

    High risk
  3. David Cosmetic Co., Ltd.

    FDA lab testing found benzene, a cancer-causing impurity, at about 6 ppm in David Cosmetic's CALA hand sanitizer, making it adulterated.

    High risk
  4. Brigham and Women’s Hospital Inc.

    Brigham and Women’s Hospital PET drug facility had water leaks and fungal contamination in aseptic areas, FDA says.

    High risk
  5. Delta 8 Hemp

    FDA warned Delta 8 Hemp over unapproved Delta-8 THC drugs and adulterated gummies sold online.

    High risk
  6. ATLRx, Inc.

    FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.

    High risk
  7. Kingdom Harvest

    Kingdom Harvest marketed CBD and Delta-8 THC products with unapproved drug claims and unsafe food and animal drug uses.

    High risk
  8. BioMD Plus LLC

    FDA warned BioMD Plus LLC that its CBD and Delta-8 THC products are unapproved drugs and its Delta-8 gummies contain an unsafe food additive.

    High risk
  9. M Six Labs, Inc.

    FDA warned M Six Labs over unapproved CBD/Delta-8 THC drugs, illegal CBD/Delta-8 foods, and animal drugs sold online.

    High risk
  10. Miami University Department of Chemistry and Biochemistry

    Miami University contract testing lab falsified heparin API test data and lacked CGMP controls.

    High risk
  11. Age Management Institute Santa Barbara

    FDA cited Age Management Institute Santa Barbara for insanitary sterile compounding of IV drugs, including dirty equipment and expired ingredients.

    High risk
  12. Froggy’s Fog LLC

    FDA warns Froggy’s Fog that its OTC hand sanitizer was made under inadequate CGMP and mislabeled for alcohol strength.

    High risk
  13. The W.S. Badger Company, Inc.

    FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.

    High risk
  14. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk
  15. Fresh Farms LLC

    FDA warned Fresh Farms LLC about manufacturing violations in OTC hand sanitizer, including untested ethanol and missing batch records.

    High risk
  16. Cetylite Industries, Inc.

    FDA warned Cetylite Industries over CGMP violations at its Pennsauken, NJ facility, including unvalidated testing and inadequate OOS investigations for topical anesthetics.

    High risk
  17. Vitae Enim Vitae Scientific Inc.

    FDA warned Vitae Enim Vitae Scientific of sterile drug CGMP violations and contamination-control failures after a 2021 inspection, leading to a recall.

    High risk
  18. Clinical Resolution Laboratory Inc.

    FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.

    High risk
  19. Kleenhanz, LLC

    FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.

    High risk
  20. Elements Brands Inc.

    FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.

    High risk
  21. Ultimark Products

    Ultimark Products sells Porcelana Day Skin Lightening Cream, an unapproved and misbranded hydroquinone skin-bleaching drug, FDA says.

    High risk
  22. SkinPro

    SkinPro sells an unapproved, misbranded hydroquinone skin-bleaching drug without FDA approval.

    High risk
  23. Skin PS Brands

    FDA warns Skin PS Brands that Dark Spot Fix, a hydroquinone skin-lightening drug, is an unapproved and misbranded new drug.

    High risk
  24. Clinical Formula LLC

    FDA warned Clinical Formula LLC that its Clinical Formula Bleaching Lotion is an unapproved and misbranded skin-lightening drug.

    Medium
  25. Neoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.

    FDA warned Neoteric Cosmetics and parent Scott's Liquid Gold that ALPHA Skin Care Dual Action Fade Cream, a hydroquinone skin lightener, is an unapproved and misbranded drug.

    Medium
  26. Dr. Thomas Balshi/Intilight

    FDA warned Dr. Thomas Balshi/Intilight that its hydroquinone skin-lightening cream is an unapproved and misbranded new drug.

    High risk
  27. Skin Authority, L.L.C.

    FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.

    High risk
  28. AMBI Enterprises LLC

    AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.

    High risk
  29. Genomma Lab USA, Inc.

    Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.

    High risk
  30. M & M Beauty and Wellness, LLC

    FDA says M & M Beauty and Wellness sells an unapproved, misbranded hydroquinone skin-lightening cream.

    High risk
  31. True Earth Health Products, LLC

    FDA warned True Earth Health Products over Plexaderm Dark Spot Fade Gel, an unapproved, misbranded hydroquinone skin-bleaching drug.

    High risk
  32. "Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases

    FDA warns clinical investigator Daniel C. Tarquinio over enrolling ineligible subjects in investigational drug trials.

    High risk
  33. Vi-Jon, LLC

    FDA cited Vi-Jon for manufacturing-rule violations after finding microbial water contamination, leaks, weak investigations, and data-integrity failures in OTC drugs and cosmetics.

    High risk
  34. www.wellerectile.com

    FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.

    High risk
  35. kubapharm.com

    FDA and DEA warned kubapharm.com it unlawfully sells high-abuse-risk stimulants, including Adderall, online without required registrations or prescriptions.

    High risk
  36. premiumlightsupplier.com

    FDA and DEA warned premiumlightsupplier.com that it unlawfully sells Schedule II stimulants, including Adderall, online without prescriptions or DEA registration.

    High risk
  37. Med Shop Total Care, Inc.

    FDA warns Med Shop Total Care about insanitary conditions in sterile drug compounding.

    High risk
  38. Ultra Seal Corporation

    FDA warns Ultra Seal and ULTRAtab over manufacturing quality failures in over-the-counter drug cleaning, testing, and release.

    High risk
  39. Generitech Corporation

    FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.

    High risk
  40. Yusef Manufacturing Laboratories, LLC

    FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.

    High risk
  41. CofixRx, LLC

    FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.

    High risk
  42. Sensory Cloud, Inc

    FDA and FTC warn Sensory Cloud that its FEND nasal mister is an unapproved, misbranded drug sold with COVID-19 prevention and treatment claims.

    High risk
  43. NDAL Mfg Inc.

    NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.

    High risk
  44. CBD Social

    FDA and FTC warn CBD Social over website claims that CBD products prevent or treat COVID-19.

    High risk
  45. Functional Remedies, LLC D/B/A Synchronicity Hemp Oil

    FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.

    High risk
  46. Greenway Herbal Products LLC

    FDA and FTC warned GreenWay Herbal Products that CBD website claims to prevent and treat COVID-19 make its products unapproved, misbranded drugs.

    High risk
  47. Cureganics

    Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.

    High risk
  48. Nature's Highway

    FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.

    High risk
  49. UPSY LLC

    FDA and FTC warned UPSY LLC that its website sells CBD products claimed to treat or prevent COVID-19 as unapproved, misbranded drugs.

    High risk
  50. Heaven’s Organic LLC

    FDA and FTC warned Heaven’s Organic LLC over CBD products sold with unapproved COVID-19 treatment and prevention claims.

    High risk